STEEL Percutaneous Coronary Intervention

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 180 participants.

Also called NCT02327624

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 180 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02327624
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02327624. Randomized; no masking; primary purpose treatment. Start 2015-06 (actual); primary completion 2018-05-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
STEEL Percutaneous Coronary Intervention
Acronym
STEEL-PCI
Intervention (Drug)
Clopidogrel
Intervention (Drug)
Ticagrelor 60
Intervention (Drug)
Ticagrelor 90
Lead sponsor
Sheffield Teaching Hospitals NHS Foundation Trust (class: other)
Collaborator
AstraZeneca (class: industry)

Record details

Record id
cardio:ct-nct02327624
Content hash
d351631c1898e27bd498de1c85cc04b0e175f2d4d88fbac0d69f459a95ff4141